NASDAQ:HZNP
Delisted

Horizon Therapeutics Public Company Stock News

etoro logo Buy HZNP
*Your capital is at risk
$116.30
+0 (+0%)
At Close: Jan 04, 2024
Horizon Therapeutics (NASDAQ:HZNP) was upgraded by equities research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a report issued on Wednesday, BidAskClub reports. Ot
Horizon Therapeutics PLC (NASDAQ:HZNP) EVP Brian K. Beeler sold 9,000 shares of Horizon Therapeutics stock in a transaction dated Thursday, April 16th. The stock was sold at an average price of $32.51
Horizon Therapeutics PLC (NASDAQ:HZNP) – Piper Sandler decreased their FY2020 earnings per share (EPS) estimates for Horizon Therapeutics in a research note issued to investors on Monday, April 13th
Horizon Therapeutics (HZNP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its first-quarter 2020 financial results will be released on Wednesday, May 6, 2020. Following the announcement, Horizon's management will
These companies scored recent drug approvals. It's worth looking into their stocks to see if they're a buy now.
Horizon Therapeutics PLC (NASDAQ:HZNP) – Equities researchers at Piper Sandler increased their Q1 2020 earnings per share estimates for shares of Horizon Therapeutics in a report released on Monday,
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Horizon Therapeutics ( HZNP – Research Report ) and Madrigal Pharmaceuticals ( MDGL – Research Repo
Macquarie Group Ltd. purchased a new stake in shares of Horizon Therapeutics PLC (NASDAQ:HZNP) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The instituti
Horizon Therapeutics (NASDAQ:HZNP) was downgraded by equities research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued on Tuesday, BidAskClub re
Cubist Systematic Strategies LLC lowered its position in shares of Horizon Therapeutics PLC (NASDAQ:HZNP) by 87.0% during the fourth quarter, according to the company in its most recent disclosure wit
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE